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The transcription factor NF-Y promotes cell proliferation and its activity often declines during
differentiation through the regulation of NF-YA, the DNA binding subunit of the complex. In
stem cell compartments, the shorter NF-YA splice variant is abundantly expressed and
sustains their expansion. Here, we report that satellite cells, the stem cell population of adult
skeletal muscle necessary for its growth and regeneration, express uniquely the longer NF-
YA isoform, majorly associated with cell differentiation. Through the generation of a condi-
tional knock out mouse model that selectively deletes the NF-YA gene in satellite cells, we
demonstrate that NF-YA expression is fundamental to preserve the pool of muscle stem cells
and ensures robust regenerative response to muscle injury. In vivo and ex vivo, satellite cells
that survive to NF-YA loss exit the quiescence and are rapidly committed to early differ-
entiation, despite delayed in the progression towards later states. In vitro results demonstrate
that NF-YA-depleted muscle stem cells accumulate DNA damage and cannot properly dif-
ferentiate. These data highlight a new scenario in stem cell biology for NF-Y activity, which is
required for efficient myogenic differentiation.
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Postnatal muscle stem cells, namely satellite cells (SCs), allowneonatal/juvenile growth phase of normal skeletal myofi-bers as well as the homeostasis and repair following injury
of adult skeletal muscle1,2. SCs are histologically located in a
niche environment between the sarcolemma and the basal lamina
of the muscle fiber. Despite heterogeneous in gene expression
signature, stemness, and myogenic differentiation potential, SCs
are characterized by the expression of the paired domain tran-
scription factor Pax73. The ablation of the total pool of Pax7+
cells in adulthood results in the complete loss of muscle
regeneration4,5. In adult muscle, Pax7+ cells are mitotically
quiescent but quickly enter the cell cycle in response to injury and
muscle degeneration to both self-renew and differentiate into
functional myofibers. A dynamic interplay exists between SCs and
the stem cell niche: the activity of SCs is influenced not only by
intrinsic factors, but also by signals provided by the niche6. In
addition, the niche has a role in the regulation of SCs asymmetric
division, which depends on the relative position of daughter cells
in relation to the myofiber7. Asymmetric division, which gen-
erates two unequal daughter cells, is a key mechanism that allows
the maintenance of the stem cells pool and tissue homeostasis by
supporting the balance between self-renewal and differentiation7.
Multiple signaling pathways and rapid expression of myogenic
transcription factors (TFs) govern SCs activation. In particular,
the early expression of Myf5 and MyoD in activated SCs controls
the myogenic program, depending on which of the two TFs
predominates: while translation of Myf5 mRNA enhances SCs
activation, MyoD mainly drives the expansion of a cell population
that is committed toward early differentiation3,8. After limited
rounds of proliferation, the majority of Pax7+ cells begin a dif-
ferentiation program characterized by MyoD-dependent activa-
tion of Myogenin and Mef2 and decrease in Pax7 levels9.
The TF NF-Y is composed by NF-YA, NF-YB, and NF-YC
subunits. NF-YA is the DNA binding subunit of the hetero-
complex, which specifically binds to CCAAT boxes, common
regulatory DNA elements within promoters and enhancers10,11.
The NF-YA gene encodes for two different splice transcripts, NF-
YA long (NF-YAl) and NF-YA short (NF-YAs), the last one
lacking 28/29 aminoacids within the transactivation domain. In
mouse embryonic stem cells (ESCs), NF-YAs is expressed in
proliferating cells and a switch to NF-YAl occurs during
differentiation12.
In mature skeletal muscle, NF-YA expression is absent and,
consequently, NF-Y binding to its target genes is lost13. NF-Y is a
well-known positive regulator of cell proliferation via transcrip-
tional activation of cell growth genes. Therefore, it is generally
accepted that the decrease in NF-YA levels is a key step that
allows the exit from the cell cycle and the activation of the
myogenic differentiation program during myoblast differentia-
tion. Indeed, transient NF-YA overexpression impairs myoblast
differentiation in vitro13,14. Despite this, we recently showed that
stable overexpression of NF-YAl in C2C12 myoblasts enhances
the differentiation program through the activation of new iden-
tified NF-Y target genes, such as Cdkn1c (p57) and Mef2d, which
are important for early muscle differentiation. Oppositely, forced
expression of NF-YAs maintains the cells into a proliferative
status and inhibits the differentiation program15. Recent results
obtained by CRISPR-Cas9 forced deletion of exon3, retained in
NF-YAl, highlighted that the switch from NF-YAl to NF-YAs
interferes with the differentiation program but not with the
proliferative ability of C2C12 cells16. While in wt mice muscle
NF-YA is undetectable, it is expressed in the nuclei of dystrophic
mdx mouse muscles, which are characterized by extensive acti-
vation of SCs to compensate myofibers degeneration. In accor-
dance with NF-YA expression, the NF-Y heterotrimer binds the
promoters of its target genes, which are upregulated in mdx
muscles14. Taking into consideration these results together with
data showing that NF-YA expression controls stemness and
proliferation of mouse and human stem cells12,17, we decided to
investigate the biology of NF-Y in muscle stem cells. Unfortu-
nately, the ability to study NF-Y in post-natal tissues has been
hampered by early embryonic lethality of NF-YA null mice18.
In this study, we used an inducible knock out mouse model to
selectively disrupt NF-YA expression in Pax7+ SCs and we
demonstrated that NF-Y has key functions in the regulation of
muscle stem cell fate. We present evidence that NF-Y is impor-
tant for adult SCs maintenance and myogenic differentiation.
Results
NF-YA is required for proper regeneration of adult skeletal
muscle following injury. We first investigated the expression of
the NF-YA subunit during embryonal and adult myogenesis.
Western blot analysis of mouse skeletal muscles highlighted that
NF-YA expression is high in embryonic myoblasts (E12) and
drops in fetal (E17) and post-natal muscles from P7 to P28
(Fig. 1a). Despite NF-YA downregulation during secondary
myogenesis and post-natal period, we decided to investigate
whether NF-YA expression could be modulated during skeletal
muscle regeneration induced in tibialis anterior (TA) of adult
mice (6–8-weeks-old mice) by cardiotoxin (CTX) injection. CTX
administration led to a significant increase in NF-YAl transcript
and upregulation of both NF-YAl and NF-YAs protein isoforms
in total muscle extracts (Fig. 1b and c). Immunofluorescence
analysis of TA muscle sections after 5 days from CTX treatment
identified NF-YA expression in some nuclei of centrally nucleated
fibers, as well as in interstitial cells that populate regenerating
muscles (Fig. 1d). The main populations involved in muscle
regeneration were isolated from CTX muscles by cell sorting and
total extracts were analyzed by western blot: while macrophages
express both NF-YAl and NF-YAs proteins, NF-YAl isoform
uniquely is detected in activated SCs and FAPs (Fibro Adipogenic
Progenitors) (Fig. 1e).
In adult life, SCs are the stem cell population responsible for
muscle regenerative capacity, therefore we decided to investigate
whether NF-YA is required for the regeneration of myofibers
upon injury. We generated NF-YAfl/fl;Pax7-Cre mice by crossing
Pax7-CreERT2 19 with NF-YAflox/flox (NF-YAfl/fl) mice, contain-
ing one LoxP site in intron 2 and one LoxP site in intron 8 of the
NF-YA gene18 (Supplementary Fig. 1a). Genetic ablation of NF-
YA expression in SCs of NF-YAfl/fl;Pax7-Cre mice was induced
by five repeated intraperitoneal (IP) injections of Tamoxifen
(TMX) followed by 7 days of chasing in 8 weeks old mice
(hereafter NF-YAcKO). NF-YAfl/fl mice treated with TMX were
used as control. PCR analysis of isolated SCs identified TMX-
induced genomic targeted-deletion of the NF-YA floxed gene and
a decrease in NF-YA wt transcript in favor of NF-YA deleted one
(Supplementary Fig. 1b and c). Quantification of NF-YA and
Pax7 double stained cells on fresh extensor digitorum longus
(EDL) myofibers isolated from NF-YAfl/fl and NF-YAcKO mice
showed TMX-induced depletion of NF-YA expression in about
70% of SCs (Supplementary Fig. 1d). NF-YAcKO mice showed
neither an overt phenotype nor differences in morphology and
fiber size distribution compared to control (Supplementary
Fig. 1e).
CTX was then injected into TA muscles of NF-YAcKO and NF-
YAfl/fl mice. H&E staining highlighted a more severe muscle
damage in NF-YAcKO than in control mice at 5 days post-
injection (Fig. 1f). At 15 days, centronuclear myofibers, indicative
of regeneration, were detected in both NF-YAfl/fl and NF-YAcKO
mice, but disorganized muscle structure and interstitial cell
infiltration were clearly evident in cKO muscles. The reduction in
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myofiber cross-sectional area (CSA) suggested a delayed regen-
erative response in NF-YAcKO mice (Fig. 1g). Moreover, cell
infiltration persisted in NF-YAcKO sections (Fig. 1h), as well as
collagen-enriched area, detected by trichrome staining, even at
day 25 from injury (Fig. 1f). The difference in CSA and
percentage of centrally nucleated myofibers between NF-YAfl/fl
and NF-YAcKO mice was still evident following 60 days after
injury and was associated with reduced muscle weight (Fig. 1g, I
and Supplementary Fig. 1f). Despite this, no defects were
observed on muscle function, at least when determined by the
conventional forelimb grip strength test (Supplementary Fig. 1g).
These results suggest that NF-YA expression in SCs could be
essential for proper timing of skeletal muscle regeneration.
NF-YA expression sustains proper regenerative myogenesis
in vivo. To investigate the effect of NF-YA decrease on
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regenerative myogenesis, we evaluated the expression of key
myogenic regulatory factors. Immunofluorescence staining of
embryonic Myosin Heavy Chain (eMyHC), a marker for actively
regenerating myofibers, showed marked expression at 5 days
post-injury in both NF-YAfl/fl and NF-YAcKO muscles. NF-YAfl/fl
samples presented abundant expression of eMyHC in fibers of
bigger size compared to NF-YAcKO. We observed an aberrant
persistence of numerous eMyHC+ myofibers at day 15 after
injury in cKO-damaged muscles (Fig. 2a), evidence of a regen-
erative delay.
By means of RT-qPCR, we compared the transcriptional
activation of myogenic markers following 5 days from injury in
total muscles in both NF-YAfl/fl and NF-YAcKO mice, relatively to
control uninjured muscles (Fig. 2b). All the examined transcripts
were induced in NF-YAfl/fl injured muscle, consistently with
active regeneration. Differently, CTX administration to
NF-YAcKO muscles did not induce significant upregulation of
Pax7 with respect to uninjured muscles. Myogenin, Myf5 and
eMyHC levels increased, albeit to a lesser extent compared to NF-
YAfl/fl. Accordingly, reduced levels of Pax7, Myogenin and
eMyHC proteins were observed in NF-YAcKO compared to NF-
YAfl/fl CTX injured muscles (Fig. 2c). Western blot on 15 days
post-injury muscles confirmed that the expression of eMyHC
persisted at abundant levels in NF-YAcKO with respect to NF-
YAfl/fl (Fig. 2d), consistently to the higher proportion of
eMyHC+ fibers observed by immunofluorescence (Fig. 2a).
These results are suggestive of a delayed regenerative process in
NF-YAcKO mice, hinting that NF-YA expression is important for
efficient muscle repair in adult mice.
NF-YA expression is regulated during SCs activation and dif-
ferentiation. To understand how NF-Y regulates post-natal myo-
genesis and muscle homeostasis, we examined the expression of NF-
YA in SCs retained on single isolated myofibers from EDL uninjured
muscles of adult wt mice (Fig. 3a). In order to discriminate quiescent,
proliferating, and differentiating SCs we fixed myofibers after isola-
tion (quiescent, Q), after 1 day (proliferating, P), and 3 days in
suspension culture (differentiating, D). We detected positive NF-YA
staining in quiescent Pax7+, activated MyoD+, and differentiating
MyoG+ SCs. The analysis of differentiating fibers stained with Pax7
highlighted that NF-YA is expressed also in self-renewing (SR) SCs20
(Fig. 3a).
We investigated the levels of NF-YA transcripts in SCs
enriched from dissociated skeletal muscle of wt mice cultured
in vitro. As already observed in immortalized myoblasts15, NF-
YAl is the most abundant transcript expressed in SC-derived
primary myoblasts (Fig. 3b). Western blot analysis of total cellular
extracts from proliferating SCs exclusively detected NF-YAl
protein (Fig. 3c). The expression of NF-YAl declines following
1 day of differentiation, concomitantly to Pax7 and MyoD
decrease and Myogenin increase, whose modulation occurs at the
transcriptional level (Fig. 3d). NF-YAl protein was barely
detectable after 5 days of differentiation, when MyHC was highly
expressed (Fig. 3c). The transcriptional control of NF-YA
expression was validated also in SCs isolated from diaphragms
of adult Pax3 GFP/+ mice21 by flow cytometry and RNA
extracted immediately after their sorting or following in vitro
culturing. Relative quantification of mRNA levels confirmed a
severe decrease of NF-YA transcripts during differentiation
(Supplementary Fig. 2a).
Disruption of NF-YA expression reduces SCs pool. Using the
NF-YAcKO mouse model, we examined whether NF-YA partici-
pates to SCs fate decision in uninjured muscle. Immuno-
fluorescence analysis revealed a clear decrease in the number of
Pax7+ cells in TA cross-sections of NF-YAcKO with respect to
control mouse muscles (Fig. 4a). The comparison between the
number of FACS-isolated SCs from control and cKO muscles
corroborated that impaired NF-YA expression triggers SCs
depletion (Fig. 4b). Tunel assay and cleaved-Caspase3 immuno-
fluorescence staining showed a significant increase in Pax7+
myonuclei of NF-YAcKO compared to NF-YAfl/fl muscles, hinting
that the reduction of Pax7+ cells can be at least in part ascribed
to cell death (Fig. 4c and d).
Relative percentages within NF-YAcKO myogenic cells in
uninjured TA sections highlighted a significant decrease of
quiescent Pax7+/MyoD- population (from 94% in NF-YAfl/fl to
90% in NF-YAcKO) at the expense of activated Pax7+/MyoD+
one (from 6% to 10%) (Fig. 4e). Consistently, we observed a
higher number of Pax7+/EdU+ cells in NF-YAcKO TA sections
following in vivo EdU administration (from 1.75% ± 0.39 to
9.61% ± 1.29) (Fig. 4f). These data suggested that NF-YAcKO SCs
are prone to exit the quiescence. Similar results were obtained in
CTX-injured muscles, where Pax7+/EdU+ cells increased from
about 33% in control muscles to 54% in NF-YAcKO ones
(Supplementary Fig. 1h).
To better understand how NF-YA loss affects SCs fate, we
monitored their myogenic progression in isolated EDL myofibers.
Similar to what was observed in TA sections, the frequency of
Pax7+ cells on total nuclei was clearly reduced in NF-YAcKO
myofibers at day 0 (d0), compared to NF-YAfl/fl ones (Fig. 4g).
Despite not statistically significant, relative cell percentages at
d0 showed a decrease in Pax7+/MyoD− in favor of Pax7+/
MyoD+ population, suggesting that the isolation procedure can
activate NF-YAcKO SCs from quiescence more quickly than NF-
YAfl/fl cells (Fig. 4h). After one day in culture (d1), NF-YAcKO
Fig. 1 NF-YA is required for proper regeneration of adult skeletal muscle following injury. a Western blot analysis of NF-YA protein levels in embryonic
(E12), fetal (E17) and post-natal (from P7 to P28) skeletal muscles. MyHCII, eMyHC and Pax7 antibodies were used to follow the myogenic progression.
n= 3 experiments. b Relative mRNA levels of NF-YA isoforms (L= long and S= short) in uninjured (control) and 5 days-injured whole TA muscle
of WT mice measured by RT-qPCR. Data represent mean ± s.d. (two-tailed unpaired t-test: p= 0.0343; *p < 0.05; n.s.= not significant; n= 3 mice).
c Representative immunoblot of NF-YA isoforms (arrows) in uninjured and 5 days-injured whole TA muscle extracts of WT mice. n= 3 experiments.
d Immunofluorescence analysis of NF-YA and laminin in TA muscle cross-sections 5 days after CTX injury and uninjured control. White and yellow arrows
indicate nuclei of regenerative myofibers and interstitial cells, respectively. n= 3 experiments, scale bar: 50 µm. e Western blot analysis of NF-YA protein
expression in sorted satellite cells (SCs), fibro/adipogenic progenitors (FAPs) and macrophage (Macr) cells from CTX-injured TA muscle. Hek293 cell
extract was used to mark the different molecular weights of NF-YA isoforms. n= 3 experiments. f Upper panel: Schematic representation of TMX and CTX
administration and time-course sample collection. Lower panel: Representative images of H&E and trichrome-stained TA cross-sections of NF-YAcKO
compared with NF-YAfl/fl mice at 5, 15, 25, and 60 days after CTX injury. n= 3 mice, scale bar: 100 µm. g Quantification of average cross-sectional area
(CSA) (5 days p= 0.0002; 15 days p < 0.0001; 25 days p= 0.0017; 60 days p= 0.002) and h, i percentage of infiltrated area (25 days p= 0.0052) and
centronucleated myofibers (5 days p= 0.0380; 15 days p= 0.0082; 25 days p= 0.0034; 60 days p= 0.0003) in TA muscle sections at days 5, 15, 25,
and 60 after CTX injection. Data represent mean ± s.d. (two-tailed unpaired t-test was used to calculate the statistical significance: **p < 0.01, ***p < 0.001;
n= 4 mice).
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Fig. 2 Loss of NF-YA delays regenerative myogenesis in vivo. a Representative immunostaining for eMyHC (red) and laminin (green) on TA muscle
sections of NF-YAfl/fl and NF-YAcKO mice 5, 15 and 25 days after CTX injury. Nuclei were identified by DAPI staining. Scale bar: 100 µm. b Relative mRNA
levels of myogenic markers Pax7, Myf5, Myogenin, eMyHC in whole 5-days injured TA muscles of NF-YAfl/fl and NF-YAcKO mice measured by RT-qPCR.
Transcript levels of NF-YAfl/fl and NF-YAcKO uninjured mice have been arbitrarily set at 1. Data represent mean ± s.d. (one-Way Anova: Pax7 F(3,8)=9.66,
p= 0.0049; Myf5 F(3,8)=44.63, p < 0.0001; MyoG F(3,8)=9,99, p= 0.0044; eMyHC F(3,8)=170.8, p < 0.0001; n= 3 mice per group. *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001 vs control; ##p < 0.01, ####p < 0.0001 vs NF-YAfl/fl). c Western blot analysis performed on whole protein extracts
of uninjured (control) and 5-days injured TA muscles of NF-YAfl/fl and NF-YAcKO mice. Immunoblots represent protein levels of Pax7, eMyHC, Myogenin
and Tubulin. n= 3 experiments. d Western blot analysis of eMyHC on whole protein extracts of 15-days injured TA muscles of NF-YAfl/fl and NF-YAcKO.
Tubulin was used as loading control. n= 3 experiments.
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fibers showed a significant increase in Pax7−/MyoD+ cells
(62.3%) compared to NF-YAfl/fl control cells (53.4%),
suggesting a quick transit of SCs from proliferation towards
differentiation commitment. At day 2 (d2), NF-YAfl/fl cells were
equally distributed between MyoD+/MyoG− and MyoD
+/MyoG+ populations, while the balance was shifted towards
MyoD+/MyoG+ (65%) in NF-YAcKO fibers. At day 3 (d3), the
distribution of NF-YAcKO cells was similar to the previous
time point, with 67% of the population still stained for MyoD+/
MyoG+ and about 30% MyoD+/MyoG−. Only 3% of
the MyoG+ cells switched off the expression of MyoD (MyoD−/
MyoG+). Differently, MyoD+/MyoG+ cells continued to
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increase (from 48 to 67%) at the expense of MyoD+/MyoG−
activated population (from 51.2 to 18.8%) in NF-YAfl/fl
myofibers. Moreover, the appearance of 14.3% MyoD−/MyoG
+ cells indicated their progression throughout the differentiation
program.
As disruption of NF-Y activity resulted in the loss of cellular
quiescence and quick commitment towards differentiation, we
assessed whether some quiescent cells executed a G0-to-
differentiation transition without passing through S phase. EdU
pulse-chase experiment on differentiating myofibers (d3) did not
identify MyoG+/EdU− cells, definitely confirming that DNA
replication occurred also in NF-YAcKO cells before they under-
took differentiation (Fig. 4i). Despite not significant, the higher
percentage of MyoG− cells within EdU+ population in NF-
YAcKO fibers is consistent with the accumulation of cells still
proliferating (Fig. 4h).
Loss of NF-Y activity impairs SCs differentiation in vitro. We
decided to monitor the proliferation and differentiation abilities
of SCs isolated from skeletal muscle of NF-YAcKO mice and
cultured in vitro. Equal number of isolated cells from NF-YAcKO
and NF-YAfl/fl muscles were plated and grown in proliferating
conditions. Cultures derived from NF-YAcKO contained a sig-
nificant lower proportion of Pax7+ cells when quantified on total
DAPI-stained nuclei (Fig. 5a, b). Relative quantification within
Pax7+ cells showed an increase in proliferating Pax7+/MyoD+
SCs (from 55.4% in control to 70.4% in NF-YAcKO) at the
expense of quiescent Pax7+/MyoD− cells in NF-YAcKO (from
44.6 to 29.6%) (Fig. 5b).
These data suggested that, despite reduced in percentage,
Pax7+ cell population from NF-YAcKO is more prone to
activation (Pax7+/MyoD+). Consistently, we observed an
increase in EdU+/Pax7+ cells, hinting that primary myoblasts
from NF-YAcKO muscle are stimulated to proliferate when
cultured in growth medium (Fig. 5c).
Despite the presence of proliferative markers, NF-YAcKO SCs
underwent a modest expansion compared to control cells, even if
maintained in culture for more days. This suggested that
following DNA replication, cell division did not really occur.
To further analyze the impact of NF-YA disruption on SCs
proliferation, we performed cell cycle analysis by flow cytometry
of Propidium Iodide-stained cells cultured in growth medium.
We observed a significant increase in S-phase cells and the
accumulation in G2/M at the expense of G0/G1 population
(Fig. 5d). The expression of the mitotic marker phospho(Ser10)-
H3 did not change compared to control cells, hinting that NF-
YAcKO SCs could be arrested in S or G2 phase (Fig. 5e).
We then investigated the differentiation commitment of SCs
cultured in low serum condition following 5 days from isolation:
fewer MyHC+ were observed in NF-YAcKO culture compared to
NF-YA-expressing cells (Fig. 5f). In order to achieve the same
confluence, NF-YAcKO cells were maintained in culture for more
days or were plated at higher density before switching to the
differentiation medium: despite this, SCs failed to efficiently
differentiate (Fig. 5f, g). Furthermore, we stained myogenic cells
with MyoD and MyoG antibodies after 1 or 2 days in
differentiating conditions (DM1 or DM2). At DM2, NF-YAcKO
cells showed different distribution compared to NF-YAfl/fl ones
(Fig. 5h). MyoD+/MyoG+ committed population increased from
49.5% ± 1.2 in NF-YAfl/fl to 63.5% ± 2.1 in NF-YAcKO at the
expense of more differentiated MyoD−/MyoG+ cells (from
32.7% ± 2.2 in NF-YAfl/fl to 18.2% ± 2.6 in NF-YAcKO). Western
blot analysis of total cellular extracts showed reduced expression
of Pax7 and MyHC in NF-YAcKO SCs cultured in growth or
differentiating medium for three days (DM3) (Fig. 5I).
These results demonstrate that NF-YAcKO SCs experienced
defects in the differentiation progression in vitro, as observed in
isolated myofibers (Fig. 4h).
Identification of NF-Y-regulated transcriptome in SCs. To
better understand the phenotype observed in primary NF-YAcKO
myoblasts, we performed RNA-seq analysis of SCs isolated from
NF-YAfl/fl and NF-YAcKO mice and cultured in growth medium.
We defined differentially expressed genes with stringent criteria
(see “Methods”) and we performed a functional analysis of
downregulated and upregulated genes. Gene Ontology analysis
identified cell cycle-related pathways as the most significantly
upregulated terms in cKO cells, in opposition to muscle cell
differentiation and contraction categories that were evidently
downregulated compared to control cells (Fig. 6a). The analysis of
TFBS (Transcription Factor Binding Sites) over-represented in
promoters (−450/+50) of differentially expressed genes identified
NF-YA and NF-YB as enriched binding sites in upregulated genes
but not in downregulated ones (Fig. 6b). These results are con-
sistent with the hypothesis that NF-Y does not directly regulate
the expression of genes involved in muscle differentiation16, while
it directly controls cell cycle genes.
We validated RNA-seq data by RT-qPCRs analysis (Supple-
mentary Fig. 3a). In accordance with RNA-seq, CcnB2, CcnA2
and TopoIIα genes, encoding for key regulators of the cell cycle,
were upregulated in NF-YAcKO primary myoblasts. In opposition,
the myogenic genes Mef2C, MyoD, and Myogenin were down-
regulated. The transcription of the cell cycle inhibitors (CDKIs)
Cdkn1A (p21), Cdkn2A (p16), and Cdkn1C (p57), which are
important in the control of proper myogenic progression,
decreased in cKO versus control cells. Taking into consideration
the reduction of Pax7+/MyoD− SCs in uninjured NF-YAcKO
muscles (Fig. 4e), we further investigated the mRNA levels of
genes implicated in quiescence and self-renewal processes
(Supplementary Fig. 3a). The expression of Sprouty1 (Spry1),
which is required for SCs self-renewal and is downregulated
during proliferation, significantly decreased in NF-YAcKO
compared to NF-YAfl/fl primary myoblasts. Similarly, transcript
levels of Notch1 and HeyL, whose knock out decreases the
number of quiescent SCs in postnatal adult muscle22,23, dropped
in NF-YAcKO. We also analyzed the expression of NF-Y subunits:
despite not significant, NF-YA decrease was concomitant to a
transcriptional upregulation of the NF-YB and NF-YC genes, as
Fig. 3 NF-YA expression is regulated during satellite cells activation and differentiation. a NF-YA immunofluorescence in Pax7+ SCs on freshly isolated
EDL myofibers (quiescent, Q), MyoD-activated SCs after 1 day in suspension culture (proliferating, P), MyoG+ differentiating (D) and Pax7+ self-renewing
(SR) SCs after 3 days in suspension culture. Nuclei were identified by DAPI staining. n= 3 mice, scale bar: 50 µm. b mRNA levels of NF-YAl and NF-YAs
transcripts in isolated SCs measured by RT-qPCR. Data represent mean ± s.d. (two-tailed unpaired t-test: p= 0.0033, *p < 0.05, n= 4 mice). c Protein
expression analysis by Western blot of NF-YA and myogenic markers (Pax7, MyoD, MyoG and MyHC) in SC-enriched cultures maintained in proliferating
(GM) or differentiating conditions for 1, 3 or 5 days (DM1, DM3, DM5). Tubulin was used as loading control. n= 3 experiments. d Relative mRNA levels of
NF-YAl (p= 0.0001, n= 4 mice), Pax7 (p < 0.0001, n= 4 mice) and Myogenin (p= 0.0212, n= 3 mice) in proliferating (GM) and differentiating (DM3)
SCs cultured in vitro. Transcript levels in GM condition have been arbitrarily set at 1. Data represent mean ± s.d. (two-tailed unpaired t-test: *p < 0.05,
***p < 0.001, ****p < 0.0001).
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shown in other conditional NF-YA knock-out mouse models
because of the negative transcriptional feedback existing between
NF-Y subunits24–26 (Supplementary Fig. 3b). The effects of NF-
YA KO on the expression levels of p57, Myogenin and NF-YB
were confirmed by western blot on total SCs extracts (Supple-
mentary Fig. 3c).
Since the upregulation of CCAAT-genes of cell cycle categories
in NF-YAcKO cells was unexpected, we decided to determine
whether NF-Y was still recruited on their regulatory regions. We
performed Chromatin IPs (ChIPs) on SCs cultured in the same
conditions used for RNA-seq profiling. The binding of NF-YA to
promoters of CcnB1, CcnB2 and TopoIIα genes was significantly
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reduced in NF-YAcKO compared to control SCs (Fig. 6c). These
results hint that transcriptional activators other than NF-Y could
be involved in maintaining active gene expression of cell cycle
genes in muscle SCs. Similarly, we checked for NF-Y binding to
regulatory regions of Cdkn1C, which we previously proved to be a
NF-Y target gene15. In NF-YAcKO SCs, we did not observe a
decrease in NF-YA binding to the canonical promoter but to the
CCAAT-box within the 5′UTR, which has a demonstrated
transcriptional regulatory function27 (Fig. 6d). Moreover, since
Myogenin is a critical node that drives myogenesis, we better
characterized its regulatory regions. We previously demonstrated
that Myogenin has a CCAAT-less promoter that coherently is not
bound by NF-Y15. Three enhancer elements controlling Myo-
genin transcription have been described, E1, E2, and E3, located
up to 7 kb from the TSS (Transcription Start Site)28,29, with E3
uniquely containing a NF-Y binding site (Supplementary Fig. 3d).
ChIP results identified NF-YA binding to the E3 enhancer that
significantly decreased in NF-YAcKO cells (Fig. 6e). Among genes
directly involved in stem cells quiescence, we analyzed whether
NF-Y directly controls Sprouty1, because of its pivotal role in the
maintenance of quiescence both in uninjured muscle and in the
return to quiescence of SCs during muscle regeneration. NF-Y
binding to the inverse CCAAT-box located at about 200 bp from
the TSS (Supplementary Fig. 3e) significantly decreased in NF-
YAcKO SCs (Fig. 6f).
Overall, the transcriptional profile of NF-YAcKO cells corro-
borated their impairment in the differentiation program through
transcriptional modulation of indirect or direct target genes, such
as Cdkn1C and Myogenin.
NF-YA depletion induces DNA damage in SCs. The analysis of
larger pathway gene sets (>500 genes) highlighted the activation
of GO pathways related to cell death/apoptosis and DNA
damage/integrity in NF-YAcKO versus NF-YAfl/fl muscle cells
(Fig. 7a). In particular, G2, intra-S, and mitotic-G2 DNA damage
checkpoint signatures were retrieved (Fig. 7b). By RT-qPCRs we
validated deregulated transcription levels of selected genes, such
as Mre11a and Rad51, involved in homologues recombination
(HR) generally restricted to the S and G2 phases, Brca1 that
belongs to the DNA damage response process (DDR), Birc5 and
Bcl2l2 that participate to the apoptotic pathway (Fig. 7c).
Taking into consideration that NF-YA loss induces DNA
damage in other cell types30 and DNA damage affects the
differentiation process31,32, we investigated whether the accumu-
lation of DNA damage can be one of the causes of impaired
differentiation in NF-YAcKO cells. We used S139-phosphorylated
histone H2AX (γH2AX) as a marker of double-strand breaks
(DSBs)33. In growth conditions, we observed a higher number of
γH2AX+/Pax7+ cells in NF-YAcKO cultures (Fig. 7d). Moreover,
western blot analysis of total extracts from NF-YAcKO compared
to NF-YAfl/fl SCs corroborated an increase in the expression of
γH2AX, as well as of MRE11A and RAD51 (Fig. 7e). Interest-
ingly, the transduction of NF-YAcKO cells with NF-YAl-lentiviral
particles decreased Mre11a and Rad51 transcriptional activation
(Fig. 7f), which reflects on protein levels (Fig. 7g). We
concomitantly observed γH2AX protein to be reduced as well
(Fig. 7g).
Therefore, our data demonstrate that NF-YA loss triggers DNA
damage in proliferating adult muscle stem cells.
Discussion
The activity of NF-Y has been extensively associated to cell cycle
progression and proliferation through the binding and direct
transcriptional activation of target CCAAT-containing genes.
Thus, it is not surprising that NF-YA, the DNA binding subunit
of the complex, is highly expressed in proliferating cells, among
which stem cells, and declines during differentiation. The
CCAAT box is one of the most overrepresented cis-regulatory
elements in human and mouse ESCs and NF-Y is necessary for
their survival and proliferation12,34,35. Jothi’s work recently
highlighted that NF-YA depletion in mouse ESCs leads to altered
structural architecture and correct positioning of the transcrip-
tional machinery at CCAAT-promoters and hence gives rise to
ectopic transcripts36.
Also in the skeletal muscle, active NF-Y ensures myoblasts
proliferation and it then becomes inactive during differentiation
through NF-YA downregulation13. In neonatal cardiomyocytes,
characterized by regenerative ability after injury, NF-YA has been
recently identified as the TF that, together with NFE2L1, effi-
ciently induces cell proliferation and survival37.
Another mechanism controlling NF-Y activity during pro-
liferation/differentiation processes relies on NF-YA splice var-
iants, NF-YAs and NF-YAl. In human hematopoietic stem cells
and mouse ESCs, the major NF-YA isoform expressed in pro-
liferating conditions is the shorter one, therefore NF-YAs has
been pointed out as the stem splice variant12,17,38. A switch from
NF-YAs to NF-YAl occurs during differentiation of ESCs and the
expression of NF-YAs in immature c-kit+ bone marrow cells
declines rapidly with terminal myeloid differentiation12,17,38.
Fig. 4 NF-YA loss reduces satellite cells pool and affects myogenic progression. a Pax7 immunostaining performed on NF-YAfl/fl and NF-YAcKO TA
muscle cross-sections (left panel) and related quantification per mm2 (right panel). Nuclei were identified by DAPI staining. Scale bar: 50 µm. The
histogram represents mean ± s.d. (two-tailed unpaired t-test: p= 0.0091, *p < 0.05; n= 6 mice). b Satellite cells were isolated from digested hindlimb
muscles of NF-YAfl/fl and NF-YAcKO mice and sorted after incubation with anti-SM/C-2.6 and anti-CD45. SCs positive to SM/C-2.6 and negative to CD45
antigens were normalized on total sorted cells and expressed in percentage. Data represent mean ± s.d. (two-tailed unpaired t-test: p= 0.0158 *p < 0.05,
n= 4 experiments). c Left panel: representative images of Tunel (green) and Pax7 (red) positive myonuclei in TA cross sections from NF-YAfl/fl and NF-
YAcKO mice. Nuclei were identified by DAPI staining. The arrows indicate double stained cells. Scale bar: 25 µm. Right panel: percentage of Tunel/Pax7
double-positive cells. Data represent mean ± s.d. (two-tailed unpaired t-test: p= 0.005, **p < 0.01; n= 3 mice). d Representative images (left panel) and
quantification (right panel) of Pax7/cleaved-Caspase-3 double stained cells in NF-YAfl/fl and NF-YAcKO TA cross sections. Scale bar: 50 µm. Data
represent mean ± s.d. (unpaired t-test: p= 0.029, *p < 0.05, n= 4 mice). e Relative quantification of myogenic cells in TA cross sections from NF-YAfl/fl
and NF-YAcKO uninjured mice. Data represent mean ± s.d. (two-tailed unpaired t-test: p= 0.0147; *p < 0.05; n= 3 mice). f Left panel: representative
images of EdU (green) and Pax7 (red) positive myonuclei in TA cross sections from NF-YAfl/fl and NF-YAcKO uninjured mice. Scale bar: 50 µm. EdU
(5mg/Kg) was injected 24 h before sacrifice. Right panel: percentage of EdU+ /Pax7+ cells in uninjured muscles. Data represent mean ± s.d. (two-tailed
unpaired t-test: p= 0.0013, **p < 0.01; n= 3 mice). g Quantification of the number of Pax7+ SC nuclei per 100 myofiber nuclei in NF-YAfl/fl and NF-YAcKO
muscles. Data represent mean ± s.d. (two-tailed unpaired t-test: p= 0.0190, *p < 0.05; n= 3 mice). h Relative distribution of myogenic cells retained in
cultured EDL myofibers at day 0, 1, 2 and 3 post- isolation. Data represent mean ± s.d. (two-tailed unpaired t-test: p values from left to right: p= 0.0142,
p= 0.0161, p= 0.0327; *p < 0.05; n= 3 mice). i Relative quantification of myogenic cells after incubation for 20 h with EdU (10 µM), cultured for 3 days
from myofibers isolation. Data represent mean ± s.d. (two-tailed unpaired t-test: n.s.= not significant; n= 3 mice).
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All together, these data suggest that NF-Y activity is high in
mitotic cells and declines during differentiation through NF-YA
regulation. Despite this, NF-Y expression and activity are critical
for the homeostasis of post-mitotic cells, such as mature neurons
of adult mouse brain24 and postnatal differentiated mouse
hepatocytes25 or adipocytes39.
Our results indicate that, in adult skeletal muscle, NF-YA is
expressed by SCs but not in the nuclei of mature myofibers.
Differently from what expected, muscle SCs express NF-YAl and
not NF-YAs, as generally observed in stem cells12,17. The
dynamics of NF-YA expression, high in proliferating and low in
differentiating SCs, suggested that NF-Y activity could be
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required for stem cell proliferation rather than differentiation.
Despite this prediction based on NF-YA expression profile, here
we described how NF-YA-depleted SCs are impaired in the dif-
ferentiation process.
Through the generation of a conditional NF-YAcKO mouse
model, in which NF-Y loss of function is exclusively induced in
Pax7+ muscle cells, we investigated the fate of SCs in uninjured
and injured muscle conditions. Uninjured muscles from NF-
YAcKO mice experience a decline in SCs pool (~40%), caused at
least in part by the activation of apoptotic cell death. Time course
analysis of isolated myofibers allowed us to better understand
naturally occurring activation and differentiation of SCs when
retained within their microenvironment. NF-YAcKO cells are
spontaneously activated and are quickly committed to early dif-
ferentiation state. However, they are delayed in subsequent steps,
as demonstrated by the lower number of MyoD−/MyoG+ cells
and the higher number of MyoD+/MyoG−, compared to NF-
YA-expressing SCs after 3 days from their activation (Fig. 4h).
Impaired differentiation ability of NF-YAcKO SCs is consistent
with the delayed regenerative response observed in NF-YAcKO
mice following muscle injury (Fig. 1). Indeed, after 60 days post-
injury, cKO muscles still show reduced CSA and a significant
increase in centrally nucleated myofibers.
To better understand which is the role of NF-Y in SCs biology,
we isolated muscle stem cells and we analyzed cell cycle pro-
gression and differentiation in vitro. Despite surviving NF-YAcKO
SCs seem to actively replicate, we observed defects in cell
expansion and differentiation, associated to impaired transition
from a MyoD+/MyoG+ state to a more differentiated MyoD−/
MyoG+ state. Even when allowed to reach the confluence, the
cells cannot activate the differentiation program efficiently
(Fig. 5).
Recent Mantovani’s work comes in support to the hypothesis
that in muscle cells the differentiation process does not depend
only on NF-YA downregulation13, as previously demonstrated,
but also on the specific NF-YA variant16. CRISPR-Cas9 forced
deletion of exon3, which leads to NF-YAl KO and NF-YAs
expression, does not result in proliferation defects but in evident
differentiation impairment in C2C12 cells16. Besides, our pre-
vious results demonstrated that stable overexpression of NF-YAl
enhances the differentiation of immortalized myoblasts that
activate a specific differentiation signature, which includes
Cdkn1C and Mef2D direct transcriptional upregulation15. All
these data are consistent with our findings that NF-YAl-depleted
SCs show defects in differentiation.
RNA-seq profiles of SCs isolated from NF-YAcKO muscles
allowed the identification of the transcriptional effects induced by
NF-YA loss (Fig. 6). Cell cycle and proliferation-related terms
increased following NF-YA KO, while muscle cell differentiation
and skeletal muscle development categories severely decreased.
The tight correlation between proliferation and differentiation
processes does not allow to clearly distinguish whether the
increase in cell cycle categories can be ascribed to a delay in the
differentiation transcriptional program or vice versa. Surprisingly,
the reduction of NF-Y binding does not affect cell cycle genes
transcription, which even increases in NF-YAcKO cells, and
therefore it seems dispensable for proliferation of muscle pro-
genitor cells. In opposition, lowered NF-Y recruitment to 5′-UTR
Cdnk1c and Myogenin E3 enhancer, regulatory regions of key
genes controlling early steps of muscle differentiation, could be
one of the reasons of impaired differentiation of SCs into myo-
tubes (Fig. 5). The identification of NF-Y binding to Myogenin
enhancer region can finally explain why forced NF-YAl expres-
sion strongly push immortalized myoblasts towards differentia-
tion, even in growth culture conditions15. That NF-Y could
regulate muscle differentiation by controlling a distal regulatory
element is in agreement with R. Jothi’s work in mouse ESCs: gene
ontology analysis identified housekeeping functions, such as cell
cycle and proliferation, as categories enriched among proximal
NF-Y target genes, and genes related to embryonic development,
particularly skeletal system and neuron development, among
those targeted by distal NF-Y sites35.
Further RNA-seq analysis identified GO categories related to
DDR (Fig. 7). We speculate that the aberrant cell cycle progres-
sion, associated to faster DNA replication, can induce DNA
damage in cultured SCs. This is consistent with our previous
observations in cultured cells: NF-YA RNAi increases the overall
velocity of replication forks and fork asymmetry, suggesting the
occurrence of fork stalling. This eventually triggers DNA damage
and cell cycle arrest40.
An intimate relationship exists between DNA replication, DNA
damage, and terminal muscle differentiation: the activation of
Fig. 5 Loss of NF-Y activity impairs satellite cells differentiation in vitro. a Representative images of NF-YAfl/fl and NF-YAcKO primary SCs
immunostained for Pax7 and DAPI after 4 days from isolation (n= 3 experiments). Scale bar: 100 µm. b Quantification of the percentage of Pax7 positive
cells normalized on total DAPI-stained nuclei in proliferating culture conditions. The indicated percentage is related to the distribution of Pax7+/MyoD+
and Pax7+/MyoD− populations. Data represent mean ± s.d. (two-tailed unpaired t-test: ****p < 0.0001, n= 3 mice). c Immunostaining (left panel) and
related quantification (right panel) of EdU+/Pax7+ cells in proliferating SCs cultures isolated from NF-YAfl/fl and NF-YAcKO. EdU (10 µM) was
administered to the cells for 2 h until harvest. Data represent mean ± s.d. (two-tailed unpaired t-test: p= 0.0215; *p < 0.05, n= 10 mice). Scale bar: 100 µm.
d Flow cytometry analysis of cell cycle progression in NF-YAfl/fl and NF-YAcKO SCs after 4 days from isolation. The histogram shows the distribution of
cells in G0/G1 (p < 0.0001), S (p= 0.0392), G2/M (p= 0.0005) and subG1 (p= 0.0336) phases of the cell cycle. Data represent mean ± s.d. (two-tailed
unpaired t-test: *p < 0.05, ***p < 0.001, ****p < 0.0001, n= 8 mice). e Western blot analysis of phospho-Ser10 histone H3 protein levels in whole-cell
extracts of proliferating SCs. Total H3 was used as loading control. n= 4 experiments. f Upper panel: schematic representation of cell culture conditions
and incubation times. GM= growth medium. Lower panel: proliferation curve at the indicated time points of NF-YAfl/fl and NF-YAcKO SCs maintained in
growth medium (solid line) or in differentiating medium (dashed lines). Data represent mean ± s.d. (two-tailed unpaired t-test: day 5 p= 0.0041;
**p < 0.05; n= 3 mice). Right panel: representative immunofluorescence images of MyHC staining of NF-YAfl/fl and NF-YAcKO SCs induced to differentiate
for 5 days following 5 or 7 days from isolation. n= 3 mice, scale bar: 100 µm. g Left panel: percentage of confluence achieved by plating different NF-YAfl/fl
and NF-YAcKO cell number. Data represent mean ± s.d. (two-tailed unpaired t-test: n.s.= not significant; n= 3 mice). Right panel: MyHC staining of NF-
YAfl/fl and NF-YAcKO confluent SCs. h Relative distribution of NF-YAfl/fl and NF-YAcKO myogenic cells induced to differentiate for 1 (DM1) or 2 days
(DM2) and stained with MyoD and MyoG antibodies. Data represent mean ± s.d. (two-tailed unpaired t-test: DM2 MyoD−/MyoG+ p= 0.0423, DM2
MyoD+/MyoG+ p= 0.0255; *p < 0.05; n= 3 mice). i Representative immunoblots of NF-YA and myogenic markers Pax7 and MyHCII protein expression
in whole extracts of SCs isolated from NF-YAfl/fl and NF-YAcKO mice and cultured in growth medium (GM) and 3 days in differentiating medium (DM3).
Vinculin was used as loading control. n= 3 experiments.
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DNA damage response in replicative senescent cells or following
the exposure of muscle cells to genotoxic stress interferes with the
activation of the myogenic program32,41. Therefore, it is likely
that DDR activation caused by NF-YA loss could induce the
differentiation checkpoint and inhibit terminal differentiation.
Overall, we provide evidence that NF-YA expression, and
hence NF-Y activity, guarantees the survival of muscle stem cells
and their efficient progression from a committed to a fully dif-
ferentiated state (Fig. 8). Our findings highlight how a well-
known cell cycle transcriptional regulator can be repurposed in
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activated stem cells to carry out key functions during myogenic
differentiation.
Methods
Mice and animal care. All animal experiments were carried out in compliance
with national ethical regulations on the protection of animals used for scientific
purposes (Italian decree no. 26 dated 04/03/2014 acknowledging European
Directive 2010/63/EU). Animal procedures and protocols were approved and
authorized by National Institute of Health (Ministero della Salute) (n. 404/2015-PR
and no. 699/2019-PR). All the experiments involving animals were approved and
supervised by the Institutional Animal Care Committee (Organismo Preposto al
Benessere Animale –OPBA- University of Modena and Reggio Emilia). The Pax7-
CreERT2 mice were kindly provided to G.M. by Prof. Shahragim Tajbakhsh,
Institut Pasteur, Paris19. NF-YAfl/fl mice were a gift from Nobuyuki Nukina’s
laboratory at Juntendo University Graduate School of Medicine (Tokyo, Japan).
The NF-YAfl/fl mice were bred with the Pax7-CreERT2 mice to generate NF-YAfl/fl;
Pax7-Cre ERT2 mice, which were used as muscle SCs-specific NF-YA knockout
mice (NF-YAcKO). All animals were housed at controlled temperature and
humidity on a 12 h light-dark cycle and provided water and food ad libitum. Mice
were genotyped by PCR of ear DNA using genotyping Kit Phire Animal Tissue
(#F140WH, Thermo Fisher Scientific) according to the manufacturer’s instruc-
tions. Primers sequences used for genotyping are described in Supplementary
Table 1.
In vivo treatment. Tamoxifen (#T5648, Merck KGaA) was dissolved in corn oil
(#C8267, Merck KGaA) at the concentration of 20 mg/ml and male mice of 6–8-
weeks old were injected intraperitoneally (0,1 mg/g of body weight) daily for 5
consecutive days to induce Cre-mediated deletion. Muscles of NF-YAcKO and
relative NF-YAfl/fl control were harvested after 7 days from the last tamoxifen
injection. To induce muscle injury, 20 µl of 10 µM Cardiotoxin (#L8102, Latoxan)
dissolved in PBS was injected intramuscularly into TA muscles the day after the last
Tamoxifen injection. TA muscles were collected from euthanized mice at 5, 15, 25
or 60 days post injury for histological and molecular analyses. The contralateral TA
muscles were used as control for molecular analysis. To analyze cell proliferation,
NF-YAcKO and NF-YAfl/fl mice were injected intraperitoneally with EdU (5 mg/kg,
#C10086 Thermo Fisher Scientific) 24 h before the sacrifice.
SCs isolation and culture. SCs were isolated from NF-YAfl/fl and NF-YAcKO 6–8-
weeks-old mice. Hindlimb muscles were dissected, mechanically cut and enzy-
matically digested for 1 h at 37 °C in DMEM medium containing 0.2% Collagenase
I (#C0130, Merck KGaA) plus 1% Penicillin/Streptomycin. Digested muscles were
mechanically disaggregated by 18-gauge needle and resuspended in manipulation
medium (DMEM, 2% FBS, 1% Penicillin/Streptomycin). Cell suspension was fil-
tered through 70 µm and 40 µm strainers, washed with manipulation medium and
centrifuged for 5 min at 500 × g. SCs were then isolated using Satellite Cell Isolation
Kit (#130-104-268, Miltenyi Biotec), by depletion of non-target cells through
magnetical labeling with a cocktail of monoclonal antibodies (CD31, CD45, CD11b
and Sca1) conjugated with MACS microbeads. NF-YAfl/fl and NF-YAcKO cells were
then counted and the same number was plated on Matrigel-coated (#354248,
Corning) petri with growth medium (40% DMEM, 40% HAM’s F12, 20%FBS, 1%
Penicillin/Streptomycin, 2.5 ng/ml human FGF-2 (#130-104-924 Miltenyi Biotec)
at 37 °C, 5% CO2. Cells were collected for analysis 4 days after plating. To analyze
cell differentiation, growth medium was replaced with differentiation medium
(DMEM, 5% horse serum, 1% Penicillin/Streptomycin) and the cells were incu-
bated for 1, 3 or 5 days, as described in the text. To achieve the confluence, NF-
YAcKO cells were allowed to grow for additional 2 days or were plated at higher
density with respect to NF-YAfl/fl.
Lentivirus transduction. Transient overexpression of NF-YAl was obtained by SCs
transduction with lentiviral particles (50 MOI) for 48 h. The cDNA of NF-YAl was
cloned via SmaI/SalI sites into SmaI/SalI pCCL minCMV-eGFP/hPGK-del-
taLNGFR vector backbone (kind gift of Vincenzo Zappavigna, University of
Modena and Reggio Emilia and Vania Broccoli, San Raffaele Scientific Institute,
Milan). The resulting construct was then sequenced and used for lentiviral pro-
duction. Lentiviral supernatants expressing empty vector and NF-YAl were
prepared by transfecting HEK293T packaging cells as previously described15.
Briefly, pCCL vector plasmids (20 μg) and second generation packaging plasmids
(5 μg of pMD2-VSVG and 15 μg of pCMV R8.91) were cotransfected into
HEK293T cells. Lentivirus-containing supernatant was collected 24 h after trans-
fection, centrifuged at 1700 × g to remove cell debris for 5 min, 0.45 μm-filtered and
frozen at −80 °C until use.
SCs sorting. SCs (myoblasts) were isolated from NF-YAfl/fl and NF-YAcKO mice as
described in Rossi et al.42. Basically, muscles were dissected, mechanically cut, and
enzymatically digested at 37 °C with a solution of Collagenase I (100 mg/ml, Merck
KGaA), Dispase (500 mg/ml, Gibco), and DNase I (100 mg/ml, Roche) in PBS
(Merck KGaA). Undigested tissue was precipitated for 5 min, the supernatant
centrifuged for 5 min at 1200 × g and cell pellet resuspended and blocked with 10%
donkey serum (Merck KGaA) in PBS for 15 min at room temperature (RT). Cells
were incubated 30 min on ice with primary antibody detecting SM/C-2.6 antigen,
biotinylated, 1:20043. After extensive washes, cells were incubated with
Streptavidin-APC (BD Pharmingen, 1:500) and CD45-FITC (Rat Anti-Mouse, 30-
F11, BD Pharmingen, 1:100), 20 min on ice. The cells were washed again and
sorted with a FACS Aria cell sorter (Beckman).
Isolation and culture of single myofibers. For single myofiber isolation, the EDL
muscle was dissected tendon to tendon from 6- to 8-weeks-old mice and enzy-
matically digested in DMEM medium supplemented with 0,2% Collagenase I
(#C0130, Merck KGaA) at 37 °C for 1 h. Post digestion, single myofibers were
released by trituration with heat-polished glass Pasteur pipettes in manipulation
medium (DMEM, 2% FBS, 1% Penicillin/Streptomycin). Floating fibers were fixed
in 4% PFA after isolation (day 0, d0) or cultured in 2.0 ml tubes with no conical
bottom (Eppendorf) in growth medium (40% DMEM, 40% HAM’s F12, 20% FBS,
1% Penicillin/Streptomycin, 2.5 ng/ml human FGF-2 (#130-104-924 Miltenyi
Biotec) for 1 (d1), 2 (d2) and 3 days (d3).
Immunofluorescence and histology. TA muscles were isolated from tendon to
tendon, included in OCT and rapidly passed in liquid nitrogen-cooled isopentane
for 1 min and left at −80 °C until processed. For histology and immuno-
fluorescence analysis, 10-μm thick cross sections were cut on a cryostat (Leica). For
the assessment of muscle morphology sections were stained with H&E (#460511-
446644, Carlo Erba), according to standard protocols. Trichrome staining was
performed by fixing sections with Bouin’s solution (#429751, Carlo Erba) for 1 h
and following procedures as described in ref. 44. For immunofluorescence analysis,
sections were fixed for 20 min with 10% Formalin Solution (#HT5014, Merck
KGaA) (except for eMyHC staining that does not require fixation), rinsed three
times with PBS for 5 min, permeabilized in methanol at −20 °C for 6 min and
further rinsed two more times with PBS. For Pax7 detection, sections were sub-
jected to the antigen unmasking treatment by boiling for 15 min in 0.01 M Na-
Citrate pH 6 solution. After letting them cool, sections were blocked with PBS/4%
BSA for 2–3 h, and then incubated with primary antibodies in PBS/4% BSA over-
night at 4 °C. After two washes with PBS, sections were incubated with secondary
antibodies (1:500, AlexaFluor Thermo Fisher Scientific) and DAPI in PBS-4% BSA
(only for Pax7 this passage was preceded by the incubation with Biotin-conjugated
anti-mouse IgG (1:1000, Jackson Immuno Research) in PBS/4% BSA for 45 min).
For EdU and Tunel detection, Click-iT EdU cell Proliferation Kit Alexafluor 488
(Thermo Fisher Scientific) and In Situ Cell Death Detection Kit, Fluorescein
(Roche) were used according to the protocol from manufacturer, respectively. After
two washes with PBS, sections were mounted with mowiol. Immunofluorescences
on single fibers were performed in suspension. Single myofibers were fixed for
10 min with 10% Formalin Solution (#HT5014, Merck KGaA) and washed twice
with PBS. Fixed myofibers were permeabilized with PBS/0,2% Triton/50 mM
NH4Cl for 10 min at RT. Myofibers were washed, blocked with PBS/2% Horse
serum (Thermo Fisher Scientific) for 1 h. Primary antibodies were incubated in
blocking mix over-night at 4 °C. After three washes with PBS, myofibers were
incubated for 1 h with secondary antibodies (1:500, AlexaFluor Thermo Fisher
Scientific) and DAPI, washed three times with PBS and mounted on slides with
mowiol. Immunofluorescences on cultured SCs were performed by fixing
cells for 10 min with 10% Formalin Solution (HT5014, Merck KGaA) and washed
twice with PBS. The cells were then permeabilized with PBS/0,05% Triton for
10 min at RT and blocked with PBS/BSA 1% (Merck KGaA) for 1 h. Primary
Fig. 6 Transcriptional effects of NF-YA KO in satellite cells. a Enriched GO terms of up- (left) and down- (right) regulated genes in NF-YAcKO versus NF-
YAfl/fl SCs. Circles are colored by adjusted p value (degree of enrichment) and their size commensurate with the number of genes belonging to the relative
term. b Enriched transcription factor motifs (TFs) in promoters of up- (left) and down- (right) regulated genes estimated with Pscan (defined as -450/
+50 bp near TSS). c qChIP analysis of NF-YA binding to promoter regions of CcnB2 (p= 0.0048), CcnB1 (p= 0.0055) and TopoIIa (p= 0.0265) genes and
to regulatory regions of the Cdkn1c gene (Cdkn1c 5′UTR p= 0.0188) (d) in NF-YAfl/fl and NF-YAcKO SCs. The satellite DNA-rich heterochromatin region of
chromosome 7 (Chrm 7) has been used as negative control region and IgG as negative control antibody. Data are presented as mean ± s.d. (two-tailed
unpaired t-test: *p < 0.05, **p < 0.01, n= 5 mice). e qChIP analysis of NF-YA binding to E3 enhancer of Myogenin gene (p= 0.0480) or to CCAAT-
promoter of Sprouty1 gene (p= 0.0194) (f). Data are presented as mean ± s.d. (two-tailed unpaired t-test: *p < 0.05, **p < 0.01, n= 4 mice).
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antibodies were incubated in blocking mix over-night at 4 °C in a humid chamber.
After three washes with PBS, the cells were incubated for 1 h with secondary
antibodies (1:500, AlexaFluor Thermo Fisher Scientific) and DAPI, washed three
times with PBS and mounted on slides with mowiol. The following primary
antibodies and dilutions were used: rabbit anti-NF-YA (1:100, Thermo
Fisher Scientific), rabbit anti-NF-YA (H-209), (1:100, sc-10779 Santa Cruz Bio-
technology), rabbit anti-laminin (1:500, ab11575 Abcam), mouse anti-Pax7 (1:100,
DSHB), mouse anti-MyHCII (MF20) (1:2, DSHB), mouse anti-eMyHC (1:50,
DSHB), rabbit anti-MyoD (C-20) (1:100, sc-304 Santa Cruz Biotechnology),
rabbit anti-MyoD (M-318) (1:100, sc-760 Santa Cruz Biotechnology), rabbit
anti-Myogenin (M-225) (1:100, sc-576 Santa Cruz Biotechnology), mouse
anti-Myogenin (1:100, M3559 Dako), anti-phospho(S139)-H2AX (1:200, #2577
Cell Signaling), rabbit anti-cleaved Caspase- 3 (D175) (1:200, #96615 Cell
Signalling).
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For EdU and Tunel detection, Click-iT EdU cell Proliferation Kit Alexafluor
488 (#C10086 Thermo Fisher Scientific) and In Situ Cell Death Detection Kit,
Fluorescein (Roche) were used according to the manufacturer’s protocol,
respectively. Images were acquired using a Zeiss AxioSkop 40 fluorescence
microscope and EVOS M5000 (Thermo Fisher Scientific) equipped with ×10 and
×20 magnification objective. CSA and infiltrated area were analyzed by ImageJ
software.
Cell cycle and proliferation analysis. Isolated SCs or EDL myofibers were treated
with EdU (10 μM, Thermo Fisher Scientific) for 2 or 20 h, respectively. For EdU
detection, cells or myofibers were fixed with 3.7% PFA, washed with PBS and
stained with the chemical reaction mix provided by Click-iT EdU Cell Proliferation
Assay kit (#C10086 Thermo Fisher Scientific). The cells were then immunostained
with primary and secondary antibodies, as described above. Flow cytometric cell
cycle analysis was performed after collecting cells by centrifugation, washed with
PBS, and resuspended in 400 µL of PI solution (0.1%, Triton, 3.4 M Na citrate,
50 µg/mL Propidium Iodide). After 30 min of incubation, cells were analyzed for
DNA content using cytofluorimeter (Beckman coulter)45.
RT-qPCR. RNA was extracted from cells by using Ripospin II mini Kit (GeneAll),
according to the manufacturer’s protocol. For cDNA synthesis, 500 ng of RNA was
retrotranscribed with PrimeScript RT Reagent Kit (TAKARA). Quantitative
RealTime PCR was performed with SsoAdvanced Universal SYBR Green Supermix
(Biorad) using Biorad CFX connect thermocycler. Oligonucleotides used were
Fig. 7 NF-YA depletion activates a DNA damage signature in satellite cells. a Enriched upregulated GO terms (>500 genes) related to cell death/
apoptosis and DNA damage/integrity processes in NF-YAcKO versus NF-YAfl/fl SCs. Circles are colored by adjusted p value (degree of enrichment) and
their size commensurate with the number of genes belonging to the relative term. b Heatmaps showing expression of MSigDB genes of DNA damage
checkpoints among samples. High expressed genes are highlighted in green, whereas low expressed genes in red. c Relative mRNA levels measured by RT-
qPCR analysis of the indicated genes in SCs isolated from NF-YAcKO versus NF-YAfl/fl mice. Data represent mean ± s.d. (two-tailed unpaired t-test: Mre11a
p= 0.0172, Rad51 p= 0.0345, Brca1 p= 0.0274, Birc5 p= 0.0476, Bcl2l2 p= 0.0370; *p < 0.05, n= 5 mice). d Immunofluorescence (left panel) images
and quantification of γH2AX+ cells calculated as proportion on Pax7+ cells (right panel) in proliferating SCs cultures isolated from NF-YAfl/fl and NF-
YAcKO. Data represent mean ± s.d. (two-tailed unpaired t-test: p= 0.0494; *p < 0.05, n= 6 mice). Scale bar: 100 µm. e Western blot analysis of DDR
markers in whole-cell extracts of NF-YAfl/fl and NF-YAcKO isolated SCs. Total histone H2A and Vinculin were used as loading control. n= 3 experiments. f
Relative transcript levels by RT-qPCR analysis of the Mre11 and Rad51 genes in NF-YAfl/fl and NF-YAcKO SCs transduced with empty or NF-YAl lentiviral
particles. Data represent mean ± s.d. (one-way ANOVA: Mre11a F(2,9)=86.44 p < 0.0001; Rad51 F(2,9)=30.08 p= 0.0001. **p < 0.05, ***p < 0.01 vs NF-
YAfl/fl; ##p < 0.05, ###p < 0.001 vs empty). g Western blot analysis of DDR markers in NF-YAcKO empty and NF-YAl-transduced satellite cells from two
independent experiments (exp1 and exp2). Total histone H2A and Vinculin were used as loading control. n= 3 experiments.
Fig. 8 Model for NF-Y role in skeletal muscle stem cells. Comparison between myogenic progression of SCs expressing physiological or reduced NF-YA
levels (blue lines=NF-YAWT; red lines=NF-YAcKO). Quiescent SCs that survive to NF-YA loss (NF-YAcKO) are quickly activated and committed to early
differentiation; nevertheless, they cannot accomplish terminal differentiation. This finally affects muscle regeneration following injury in NF-YAcKO mice.
The predominant phases and related markers involved in early and late stages of SCs differentiation are indicated. Created with BioRender.com.
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designed to amplify 100–200 bp fragments: sequences are listed in Supplementary
Table 2. The relative quantification of gene expression was calculated with the
formula 2–(ΔΔCt) and normalized on the housekeeping gene Rps15.
RNA sequencing. RNA was quantified using Nanodrop (Thermo Fisher Scientific,
Waltham, Massachusetts, USA) and quality assessment was performed by Bioa-
nalyzer RNA 6000 nano kit (Agilent Technologies, Santa Clara, California, USA).
RNAseq libraries were obtained starting from 500 ng of total RNA following
Illumina TruSeq Stranded Total RNA preparation protocol. Sequencing was per-
formed using Illumina NextSeq high-output cartridge (2 × 75).
RNA-seq data analysis. Raw data were aligned to mouse transcriptome (mm10)
through bowtie246. Gene expression was quantified with RSEM 1.3.147. Genes with
more than 10 counts in at least two samples were kept. DESeq2 1.38 R package was
employed to normalize read counts and to compute differentially expressed genes;
genes with FDR < 0.01 and which Log2FC was either >1 or <−1 were considered
significant. Over-represented TFs motifs in the promoter (defined as −450/+50 bp
near TSS) of up- and downregulated genes were estimated with Pscan48, employing
non-redundant JASPAR 2018 set of matrices. Enriched GO Terms and Pathways,
in the two gene lists, were computed by KOBAS 3.0 set for Fisher exact Test and
Benjamini and Hochberg p-value correction49. Resulted GO Terms and Pathways
with adjusted p-value lower than 10−5 were considered significant. Besides, to
stand up mostly meaningful categories we discarded enriched GO Terms with
background genes number higher than 500.
Immunoblots. Whole-cell protein extracts were prepared by resuspending cells
into 1X SDS sample buffer (25 mM TrisHCl pH 6.8, 1.5 mM EDTA, 20% glycerol,
2% SDS, 5% β-mercaptoethanol, 0.0025% Bromophenol blue). Fractioned protein
extracts of TA muscles were obtained homogenizing tissues in 200–500 µl of STM
buffer (250 mM sucrose, 50 mM Tris–HCl pH 7.4, 5 mM MgCl2, protease, and
phosphatase inhibitor cocktails) for 1 min on ice using the TissueRaptor (Qiagen).
The homogenate was maintained on ice for 30 min, vortexed and centrifuged at
800 g for 15 min. The supernatant (cytosolic fraction) was collected while the pellet
was washed with STM buffer, centrifuged, and resuspended in 200–500 μl NET
buffer (20 mM HEPES pH 7.9, 1.5 mM MgCl2, 0.5 M NaCl, 0.2 mM EDTA, 20%
glycerol, 1%Triton-X-100, protease and phosphatase inhibitors). The nuclear
fraction was vortexed, incubated on ice for 30 min, and lysed with 10 passages
through an 18-gauge needle. The nuclear lysate was centrifuged at 9000 × g for
30 min, at 4 °C, the resultant supernatant represented the soluble nuclear
fraction50. For immunoblotting equivalent amounts of cellular extracts were
resolved by SDS-PAGE, electrotransferred to PVDF membrane (GE Healthcare)
and immunoblotted with the following primary antibodies diluted in TBS 1X- BSA
1 μg/μl: mouse anti-NF-YA (G2) (1:1000, sc-17753, Santa Cruz Biotechnology),
mouse anti-Pax7 (1:1000, DSHB), mouse anti-MyHCII (MF20) (1:50, DSHB),
rabbit anti-Myogenin (M-225) (1:1000, sc-576 Santa Cruz Biotechnology), mouse
anti-eMyHC (1:50, DSHB), rabbit anti-MyoD (C-20) (1:1000, sc-304 Santa Cruz
Biotechnology), rabbit anti-MyoD (1:1000, 18943-1-AP Proteintech), rabbit anti-
phospho(S10)-histone H3 (1:1000, #06-750 Millipore), goat anti-histone H3
(1:1000, sc-8654 Santa Cruz Biotechnology), rabbit anti-MRE11A (1:1000, E-AB-
11403 Elabscience), rabbit anti-RAD51 (H-92) (1:1000, sc-8349 Santa Cruz Bio-
technology), rabbit anti-phospho(S139)-H2AX (1:1000, #2577 Cell Signaling),
rabbit anti-histone H2A (1:1000, Ab18255 Abcam), goat anti-Actin (I-19) (1:5000,
sc-1616, Santa Cruz Biotechnology), mouse anti-Vinculin (V4504, Merck KGaA),
rabbit anti-GAPDH (1:1000, sc-47727 Santa Cruz Biotechnology), mouse
anti-Tubulin (1:1000, 66031 Proteintech Europe), mouse anti-p57Kip2 (66794,
Proteintech Europe), rabbit anti-NF-YB (GeneSpin). Membranes were blotted
and scanned with Amersham Imager AI680 RGB (GE Healthcare), using chemi-
luminescent detection reagents Westar ηC and Supernova HRP substrates
(Cyanagen).
Chromatin immunoprecipitation. Cultured SCs were incubated for 10 min
with 1% formaldehyde; after quenching the reaction with 0.1 M glycine and nuclear
fraction was sonicated to obtain 500–800-bp DNA fragments. The chromatin
solution was precleared by adding protein G-agarose (#5720-0002 KPL) for 2 h at
4 °C, aliquoted and incubated with 4 µg of anti-NF-YA (#C15310261, Diagenode)
or rabbit IgG (sc-2027, Santa Cruz Biotechnology) overnight at 4 °C on a
rotating wheel. Before use, protein G-agarose was blocked twice at 4 °C with 1 μg/μl
salmon sperm DNA sheared at 500 bp length and 1 μg/μl BSA for 2 h. After
washes of the protein G-agarose, DNAs were isolated by phenol-chloroform
extraction and resuspended in TE buffer15. Quantitative Real-Time PCR was
performed using with SsoAdvanced Universal SYBR Green Supermix (Biorad) in
the Biorad CFX connect machine. Sequences of primers used are listed in Sup-
plementary Table 3.
Statistical analysis. All data shown in graphs represent the mean of at least three
independent experiments or mice ± s.d. values. All statistical analyses were per-
formed using GraphPad PRISM 6.0 software using one-way ANOVA or two-tailed
unpaired Student’s t-test, as appropriate. p values of p < 0.05 were considered to be
statistically significant (*), p < 0.01 (**), p < 0.001 (***), and p < 0.0001 (****),
n.s.: not significant (p ≥ 0.05).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
RNA-seq data generated in this study have been deposited in the Gene Expression
Omnibus (GEO) database under the accession code GSE154017. All raw data generated
in this study are provided in the Source Data file. Source data are provided with
this paper.
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